These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9739917)
61. Preliminary skin blood flow measurements appear unsuccessful for assessing topical corticosteroid effect. Amantea M; Tur E; Maibach HI; Guy RH Arch Dermatol Res; 1983; 275(6):419-20. PubMed ID: 6660915 [No Abstract] [Full Text] [Related]
62. Topical antipsoriatics. Smith KC; Lebwohl M Skin Therapy Lett; 2000; 5(2):1-2. PubMed ID: 10751842 [TBL] [Abstract][Full Text] [Related]
63. [A new type of topical corticoid. Principle and experimental activity control]. Escande JP Nouv Presse Med; 1972 Jan; 1(3):181-2. PubMed ID: 5061528 [No Abstract] [Full Text] [Related]
64. Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption. Nguyen V; Cunningham BB; Eichenfield LF; Alió AB; Buka RL J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S123-5. PubMed ID: 17938025 [No Abstract] [Full Text] [Related]
65. What should we know about hypersensitivity to peanuts in topical preparations. Gorgievska Sukarovska B; Lipozencić J; Stajminger G Acta Dermatovenerol Croat; 2007; 15(4):269-71. PubMed ID: 18093458 [No Abstract] [Full Text] [Related]
67. [Monthly question: local or systemic treatment: what is your choice?]. Ann Dermatol Venereol; 1997; 124(5):428-30. PubMed ID: 9739905 [No Abstract] [Full Text] [Related]
69. In vitro and in vivo percutaneous absorption of retinol from cosmetic formulations: significance of the skin reservoir and prediction of systemic absorption. Yourick JJ; Jung CT; Bronaugh RL Toxicol Appl Pharmacol; 2008 Aug; 231(1):117-21. PubMed ID: 18511092 [TBL] [Abstract][Full Text] [Related]
70. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability. Wiedersberg S; Naik A; Leopold CS; Guy RH Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322 [TBL] [Abstract][Full Text] [Related]
71. [Prescription reference--drug vehicle system: decisive for effect]. Wolf G Hautarzt; 2007 Dec; 58(12):1008-9. PubMed ID: 18368698 [No Abstract] [Full Text] [Related]
72. Collagen solubility correlates with skin optical clearing. Hirshburg J; Choi B; Nelson JS; Yeh AT J Biomed Opt; 2006; 11(4):040501. PubMed ID: 16965124 [TBL] [Abstract][Full Text] [Related]
73. [Systemic side-effects of topical preparations in children (author's transl)]. Saurat JH Ann Pediatr (Paris); 1982 Jan; 29(1):8-14. PubMed ID: 7055364 [No Abstract] [Full Text] [Related]
74. [Percutaneous absorption of heparin: a critical review of experimental results]. Sznitowska M; Janicki S Pol Merkur Lekarski; 2000 Jan; 7(43):58-63. PubMed ID: 10765658 [TBL] [Abstract][Full Text] [Related]
75. [Nipiopharmacology from the dermatologic pint of view]. Gomirato Sandrucci M; Bonu G Minerva Nipiol; 1968; 18(2):51-60. PubMed ID: 5744924 [No Abstract] [Full Text] [Related]
76. Moisturizers: what they are and how they work. Lynde CW Skin Therapy Lett; 2001 Dec; 6(13):3-5. PubMed ID: 11813097 [TBL] [Abstract][Full Text] [Related]
77. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. Dubina MI; Fleischer AB Arch Dermatol; 2009 Sep; 145(9):1027-9. PubMed ID: 19770443 [TBL] [Abstract][Full Text] [Related]